Cargando…

Once Weekly Basal Insulin Fc (BIF) is Safe and Efficacious in Patients with Type 2 Diabetes Mellitus (T2DM) Previously Treated With Basal Insulin

Basal insulin Fc (BIF; LY3209590) is a novel, once-weekly, long-acting IgG Fc-fusion protein that is being assessed for the treatment of diabetes mellitus. The presented study evaluated the safety and efficacy of BIF compared to insulin degludec over 32 weeks in patients with T2DM previously treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frias, Juan Pablo, Chien, Jenny, Zhang, Qianyi, Chigutsa, Emmanuel, Landschulz, William, Wullenweber, Paula, Haupt, Axel, Kazda, Christof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090036/ http://dx.doi.org/10.1210/jendso/bvab048.916

Ejemplares similares

Preclinical Characterization of Once Weekly Basal Insulin Fc (BIF)
por: Moyers, Julie S, et al.
Publicado: (2021)

Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes
por: Kazda, Christof M., et al.
Publicado: (2023)

Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial
por: Bue-Valleskey, Juliana M., et al.
Publicado: (2023)

SAT-LB026 Basal-Prandial Insulin versus Basal-Sliding-Scale Insulin in the Management of Hyperglycemia in Non-Critically Ill Hospitalized Patients
por: Malkhasyan, Victoria, et al.
Publicado: (2019)

Combination Therapy With Premixed & Basal Insulin Analogues in Asian Indians With Type 2 Diabetes
por: Srivastava, Brijendra Kumar, et al.
Publicado: (2021)

Predicting the Need for Basal-Bolus Insulin in Hospitalized Patients With Hyperglycemia: Is Sliding Scale Sometimes the Answer?
por: Jankovic, Ivana, et al.
Publicado: (2021)

Reconsidering the Basal Proportion of Insulin Dose: Glycemic and Microvascular Outcomes in Type 1 Diabetes Mellitus
por: Pozos-Varela, Francisco Javier, et al.
Publicado: (2021)

Trajectory of Glycated Hemoglobin Over Time Among Obese Type 2 Diabetes Patients on U-100 Basal-Bolus Insulin Regimen Using Real-World Data
por: Chen, Jieling, et al.
Publicado: (2021)

Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

FRI642 The Effect Of Early Basal Insulin Administration On Diabetic Ketoacidosis (DKA) Management
por: Al-Marsumi, Hadeel, et al.
Publicado: (2023)

SUN-186 Insulin Antibody Associated Severe Insulin Resistance Leading to Uncontrolled Hyperglycemia
por: Amir, Hajira, et al.
Publicado: (2019)

Clozapine Induced Insulin Dependence
por: McCalmon, Sean, et al.
Publicado: (2021)

SUN-649 Metabolic and Functional Regulation of T Cells by Insulin and Insulin like Growth Factor 1
por: Kiernan, Kaitlin, et al.
Publicado: (2020)

SAT-665 A Case of Hyperglycemia in Post Pancreas Transplant Patient-Is It Insulin Deficiency or Insulin Resistance
por: Polavarapu, Preethi, et al.
Publicado: (2020)

SUN-182 When Insulin Is Not Enough...
por: DiCenso, Daniela, et al.
Publicado: (2019)

SUN-685 Approach to a Potential Liver Transplant Candidate with Insulin Antibody-Mediated Severe Insulin Resistance
por: Brooks, Danielle C, et al.
Publicado: (2020)

SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
por: Oprea, Mihaela, et al.
Publicado: (2019)

OR30-04 Autonomous Drone Delivery of Insulin
por: O’Keeffe, Derek Timothy, et al.
Publicado: (2020)

PSUN227 A retrospective comparison of Basal Bolus using Glargine U-300 and Glulisine with Premix Insulin
por: Abraham, Santhosh, et al.
Publicado: (2022)

MON-640 Endogenous Insulin and C-Peptide Suppression Test Using a Rapid-Acting Insulin Analog in the Diagnosis of Insulinoma
por: Laotaveerungrueng, Nattapong, et al.
Publicado: (2020)

SUN-LB029 A Case of Gestational Diabetes with Diabetic Ketoacidosis, Insulin Injection Site Reaction and Anti Insulin Antibodies in Pregnancy
por: Hakimian, Stephanie, et al.
Publicado: (2019)

OR08-02 Do OGTT-based Insulin Secretory Response Measures Approximate 1(st) Phase Insulin Response in Pregnant Women?
por: Powe, Camille Elise, et al.
Publicado: (2020)

OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes
por: Mora, Pablo, et al.
Publicado: (2020)

SUN-179 Prolonged Hypoglycemia from Insulin Degludec
por: Kothari, Vallari, et al.
Publicado: (2019)

A Case of Autoimmune Hypoglycemia (Insulin Autoimmune Syndrome)
por: Mon Myint, Myat Su, et al.
Publicado: (2021)

SAT-624 Predictive Ability of Lipoprotein Insulin Resistance (LPIR) Score in South Asians: A Comparison of Surrogate Indices of Insulin Sensitivity/Resistance
por: Fosam, Andin, et al.
Publicado: (2020)

SUN-681 Does Short Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Mellitus Delay Eventual Insulin Dependence
por: Patil, Madhuri, et al.
Publicado: (2020)

Mild Cognitive Impairment Screening in Older Adults With Type 2 DM
por: Pirela, Daniela Victoria, et al.
Publicado: (2021)

Association Between Metformin and Prevention of Dementia in T2DM Adult Patients
por: dos Santos, Natalia Moles, et al.
Publicado: (2021)

OR31-4 Neonatal Vitamin D Deficiency and Insulin Resistance
por: McNerney, Kyle, et al.
Publicado: (2019)

SUN-166 Insulin Dose Calculator in a Pediatric Hospital
por: Shaaban, Sarah, et al.
Publicado: (2019)

Inpatient Glycaemic Control is Poor in Patients Receiving Insulin Therapy
por: Reidy, Niall, et al.
Publicado: (2021)

The IgG Antibody Paradox in Insulin Resistance: Pathogenic and Therapeutic
por: Lipchik, Andrew, et al.
Publicado: (2021)

LBSUN319 Characteristics And Treatment Patterns Of Hispanic/latino Patients Initiating First Injectable Glp-1ra Or Basal Insulin
por: Hoog, Meredith, et al.
Publicado: (2022)

FRI638 Glycemic And Cost Outcomes In Hispanic/Latino People With Type 2 Diabetes Initiating Dulaglutide Or Basal Insulin In The US
por: Hoog, Meredith, et al.
Publicado: (2023)

MON-152 Less Is More: Human Regular U-500 Insulin
por: Lugo Lopez, Zahira, et al.
Publicado: (2019)

SUN-125 Role of Various Insulin Assays in the Diagnosis of Factitious Hypoglycemia
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2019)

MON-647 Mechanisms of Insulin Resistance in Skeletal Muscle in Women with PCOS
por: Moreno-Asso, Alba, et al.
Publicado: (2020)

MON-686 Insulin Autoimmune Syndrome as a Rare Cause of Hypoglycemia
por: Mokhtar, Marwa, et al.
Publicado: (2020)

Prolonged Hypoglycemic Effect Due to Intentional Massive Insulin Glargine Overdose
por: Gill, Kirit S, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e3j6pa2j5dvm477pk9u941rmk4